Rocket Lab's $85–$90 Price Targets Survive a Sector-Wide Reset
Published on 10/11/2026 at 10:02 | Editorial boerse-global.de
A wave of risk aversion swept through global markets last week, and space stocks were not spared. Rising US Treasury yields and firming oil prices pushed investors toward the exits, with technology and growth names bearing the brunt of the selling. Rocket Lab found itself caught in that broad rotation — not, according to media reports, because of anything the company did wrong.
The stock closed Friday at €60.90, capping a seven-day stretch that shaved 7.3% off its value. That leaves the shares a striking 54% below their 52-week high of €133.80, a gap that tells you more about the market's mood than about the launch business underneath it.
Wall Street Trims the Numbers, Not the Rating
The sector-wide reassessment rippled straight into analysts' models. Gautam Khanna of TD Cowen cut his price target to $90 from $120 while keeping his Buy rating intact — a revision he attributed explicitly to a disorderly valuation adjustment across aerospace and defense names rather than to any company-specific deterioration. Barclays, meanwhile, initiated coverage with an Overweight rating and an $85 target. Both houses still see meaningful upside from current levels, even after the recalibration.
That distinction matters. A lower target is not the same as a lost thesis, and in this case the analysts were explicit about which one they were delivering.
Should investors sell immediately? Or is it worth buying Rocket Lab?
A Backlog That Doesn't Blink
While the tape was busy repricing the sector, Rocket Lab was busy signing contracts. Roughly a week ago the company unveiled a multi-year agreement with Japan's Synspective covering 20 dedicated Electron launches, scheduled to fly annually between 2028 and 2031. Rocket Lab called it the largest commercial Electron deal in its history, and it pushed the total Electron manifest past 100 missions.
The timing was fitting. Not long before the announcement, the 97th Electron mission had successfully delivered a satellite to orbit for the very same customer — a quiet demonstration of the reliability that underpins a deal of this length. For a launch provider, a backlog of this size means something concrete: committed revenue stretching across multiple years and a customer relationship deep enough to survive a few bad weeks on the Nasdaq.
Reading the Insider Filing Correctly
One item that tends to unsettle retail investors showed up in the mandatory disclosures. CFO Adam C. Spice exercised options on 140,157 shares at $1.09 apiece on October 1 and sold the same number of shares that day in three tranches. On its face, the optics look poor.
The mechanics tell a different story. The transaction was executed under a Rule 10b5-1 trading plan adopted on June 3, 2026 — a pre-scheduled, automated arrangement that removes discretion from the seller. It was not a spontaneous signal of waning confidence in the company's prospects, and treating it as one misreads the filing.
What the Selloff Actually Reflects
Strip away the macro noise — the yield curve, the crude price, the sector-wide de-rating — and the operating picture looks considerably steadier than the chart suggests. Rocket Lab is booking long-duration commercial contracts, flying them reliably, and drawing constructive coverage from major banks even as those banks mark down their targets.
None of that guarantees the shares will snap back quickly. But the gap between a 54% drawdown and a record order book is the kind of disconnect that patient investors tend to notice before the crowd does.
Ad
Rocket Lab Stock: New Analysis - 11 October
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
